1
|
Whole-body protein kinetic models to quantify the anabolic response to dietary protein consumption. CLINICAL NUTRITION OPEN SCIENCE 2021. [DOI: 10.1016/j.nutos.2021.02.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
|
2
|
Wolfe RR, Park S, Kim IY, Moughan PJ, Ferrando AA. Advances in stable isotope tracer methodology part 2: new thoughts about an “old” method—measurement of whole body protein synthesis and breakdown in the fed state. J Investig Med 2019; 68:11-15. [DOI: 10.1136/jim-2019-001108] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/01/2019] [Indexed: 11/03/2022]
Abstract
Whole-body protein turnover (protein synthesis, breakdown, and net balance) model enables quantification of the response to a variety of circumstances, including the response to meal feeding. In the fed state, the whole-body protein turnover model requires taking account of the contribution of absorbed tracee to the observed total appearance of tracee in the peripheral blood (exogenous appearance, RaEXO). There are different approaches to estimating RaEXO. The use of an intrinsically labeled dietary protein is based on the overriding assumption that the appearance in the peripheral circulation of a tracer amino acid incorporated into a dietary protein is exactly proportional to the appearance of absorbed tracee. The bioavailability approach is based on the true ileal digestibility of the dietary protein and the irreversible loss of the tracee in the splanchnic bed via hydroxylation of the tracee (phenylalanine). Finally, RaEXO can be estimated as the increase above the basal rate of appearance of the tracee using traditional tracer dilution methodology. In this paper, we discuss the pros and cons of each approach and conclude that the bioavailability method is the least likely to introduce systematic errors and is therefore the preferable approach.
Collapse
|
3
|
Nobis S, Morin A, Achamrah N, Belmonte L, Legrand R, Chan P, do Rego JL, Vaudry D, Gourcerol G, Déchelotte P, Goichon A, Coëffier M. Delayed gastric emptying and altered antrum protein metabolism during activity-based anorexia. Neurogastroenterol Motil 2018; 30:e13305. [PMID: 29411462 DOI: 10.1111/nmo.13305] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2017] [Accepted: 01/05/2018] [Indexed: 12/17/2022]
Abstract
BACKGROUND Anorexia nervosa, a restrictive eating disorder, is often associated with gastrointestinal disorders, particularly a delayed gastric emptying. However, the mechanisms remained poorly documented. Thus, we aimed to evaluate gastric emptying and antrum protein metabolism in the Activity-Based Anorexia model (ABA). METHODS Females C57Bl/6 mice were randomized into 3 groups: Control, ABA, and Limited Food Access (LFA). Food access has been progressively limited from 6 h/day at day 6 to 3 h/day at day 9 and until day 17. ABA mice had free access to an activity wheel. Gastric emptying was assessed. On gastric extracts, a proteomic analysis was performed, as well as an evaluation of protein synthesis and protein oxidation. KEY RESULTS Both LFA and ABA mice exhibited a delayed gastric emptying compared with Controls (P < .05). Proteomic approach revealed 15 proteins that were differentially expressed. Among these proteins, we identified 2 clusters of interest contributing to (i) the organization of muscle fiber with ACTA2, VCL, KRT19, KRT8, and DES proteins and (ii) "heat shock proteins" with STIP1, HSPD1, and HSPA8 proteins. ABA mice specifically exhibited an increased rate of gastric oxidized proteins. CONCLUSIONS AND INFERENCES Delayed gastric emptying observed in anorectic conditions appears to be secondary to malnutrition. However, an oxidative stress is specifically present in the stomach of ABA mice. Its role remains to be further studied.
Collapse
Affiliation(s)
- S Nobis
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France
| | - A Morin
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France
| | - N Achamrah
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Nutrition Department, Rouen University Hospital, Rouen, France
| | - L Belmonte
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Nutrition Department, Rouen University Hospital, Rouen, France
| | - R Legrand
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France
| | - P Chan
- Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Platform in proteomics PISSARO, UNIROUEN, Normandie University, Rouen, France
| | - J-L do Rego
- Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Animal Behaviour Platform SCAC, UNIROUEN, Normandie University, Rouen, France
| | - D Vaudry
- Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Platform in proteomics PISSARO, UNIROUEN, Normandie University, Rouen, France.,INSERM Unit 1239, UNIROUEN, Normandie University, Rouen, France
| | - G Gourcerol
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Physiology Department, Rouen University Hospital, Rouen, France
| | - P Déchelotte
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Nutrition Department, Rouen University Hospital, Rouen, France
| | - A Goichon
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France
| | - M Coëffier
- INSERM Unit 1073, UNIROUEN, Normandie University, Rouen, France.,Institute for Research and Innovation in Biomedicine (IRIB), UNIROUEN, Normandie University, Rouen, France.,Nutrition Department, Rouen University Hospital, Rouen, France
| |
Collapse
|
4
|
Achamrah N, Déchelotte P, Coëffier M. Glutamine and the regulation of intestinal permeability: from bench to bedside. Curr Opin Clin Nutr Metab Care 2017; 20:86-91. [PMID: 27749689 DOI: 10.1097/mco.0000000000000339] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
PURPOSE OF REVIEW Glutamine is the most abundant amino acid in plasma and plays a key role in maintaining the integrity of intestinal barrier. RECENT FINDINGS Experimental studies showed that glutamine is able to modulate intestinal permeability and tight junction protein expression in several conditions. Recent articles underlined its putative beneficial role in gastrointestinal disorders such as irritable bowel syndrome. SUMMARY Glutamine is a major nutrient to maintain intestinal barrier function in animals and humans. Depletion of glutamine results in villus atrophy, decreased expression of tight junction proteins and increased intestinal permeability. Moreover, glutamine supplementation can improve gut barrier function in several experimental conditions of injury and in some clinical situations. Furthermore, preventive effects of glutamine in experimental models of intestinal injuries have been recently reported. Despite promising data in experimental models, further studies are needed to evaluate glutamine supplementation in clinical practice.
Collapse
Affiliation(s)
- Najate Achamrah
- aNormandie Univ bINSERM UMR 1073 'Nutrition, Inflammation and Dysfunction of Gut-brain Axis', University of Rouen cNutrition Department, Rouen University Hospital, Rouen, France
| | | | | |
Collapse
|
5
|
Ghouzali I, Lemaitre C, Bahlouli W, Azhar S, Bôle-Feysot C, Meleine M, Ducrotté P, Déchelotte P, Coëffier M. Targeting immunoproteasome and glutamine supplementation prevent intestinal hyperpermeability. Biochim Biophys Acta Gen Subj 2016; 1861:3278-3288. [PMID: 27544233 DOI: 10.1016/j.bbagen.2016.08.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 07/15/2016] [Accepted: 08/15/2016] [Indexed: 02/08/2023]
Abstract
BACKGROUND Intestinal hyperpermeability has been reported in several intestinal and non-intestinal disorders. We aimed to investigate the role of the ubiquitin proteasome system in gut barrier regulation in two mice models: the water avoidance stress model (WAS) and a post-inflammatory model (post-TNBS). METHODS Both models were applied in C57BL/6 male mice (n=7-8/group); Proteasome was targeted by injection of a selective proteasome inhibitor or by using knock-out mice for β2i proteasome subunit. Finally, glutamine supplementation was evaluated. RESULTS In both models (WAS at day 10, post-TNBS at day 28), we observed an increase in proteasome trypsin-like activity and in inducible β2/constitutive β2 subunit protein expression ratio, associated with an increase in intestinal permeability. Moreover, intestinal hyperpermeability was blunted by intraperitoneal injection of selective proteasome inhibitor in WAS and post-TNBS mice. Of note, knock-out mice for the β2i subunit exhibited a significant decrease in intestinal permeability and fecal pellet output during WAS. Glutamine supplementation also improved colonic permeability in both models. CONCLUSIONS In conclusion, the proteasome system is altered in the colonic mucosa of WAS and post-TNBS mice with increased trypsin-like activity. Associated intestinal hyperpermeability was blunted by immunoproteasome inhibition.
Collapse
Affiliation(s)
- Ibtissem Ghouzali
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France
| | - Caroline Lemaitre
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France; Department of Gastroenterology, Rouen University Hospital, Rouen, France
| | - Wafa Bahlouli
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France
| | - Saïda Azhar
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France
| | - Christine Bôle-Feysot
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France
| | - Mathieu Meleine
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France
| | - Philippe Ducrotté
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France; Department of Gastroenterology, Rouen University Hospital, Rouen, France
| | - Pierre Déchelotte
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France; Department of Nutrition, Rouen University Hospital, Rouen, France
| | - Moïse Coëffier
- Normandie Univ, INSERM unit 1073, Nutrition, Inflammation and Gut-brain axis, Rouen, France; Rouen University, Institute for Research and Innovation in Biomedicine, Rouen, France; Department of Nutrition, Rouen University Hospital, Rouen, France.
| |
Collapse
|
6
|
Abstract
Glutamine, reviewed extensively in the last century, is a key substrate for the splanchnic bed in the whole body and is a nutrient of particular interest in gastrointestinal research. A marked decrease in the plasma glutamine concentration has recently been observed in neonates and adults during acute illness and stress. Although some studies in newborns have shown parenteral and enteral supplementation with glutamine to be of benefit (by decreasing proteolysis and activating the immune system), clinical trials have not demonstrated prolonged advantages such as reductions in mortality or risk of infections in adults. In addition, glutamine is not able to combat the muscle wasting associated with disease or age-related sarcopenia. Oral glutamine supplementation initiated before advanced age in rats increases gut mass and improves the villus height of mucosa, thereby preventing the gut atrophy encountered in advanced age. Enterocytes from very old rats continuously metabolize glutamine into citrulline, which allowed, for the first time, the use of citrulline as a noninvasive marker of intestinal atrophy induced by advanced age.
Collapse
Affiliation(s)
- Dominique Meynial-Denis
- D. Meynial-Denis is with the Unit of Human Nutrition (UNH), French National Institute for Agricultural Research (INRA), Joint Research Unit (UMR) 1019, Center for Research in Human Nutrition (CRNH) Auvergne, Clermont-Ferrand, France.
| |
Collapse
|
7
|
Achamrah N, Nobis S, Breton J, Jésus P, Belmonte L, Maurer B, Legrand R, Bôle-Feysot C, Rego JLD, Goichon A, Rego JCD, Déchelotte P, Fetissov SO, Claeyssens S, Coëffier M. Maintaining physical activity during refeeding improves body composition, intestinal hyperpermeability and behavior in anorectic mice. Sci Rep 2016; 6:21887. [PMID: 26906060 PMCID: PMC4764812 DOI: 10.1038/srep21887] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2015] [Accepted: 02/03/2016] [Indexed: 12/18/2022] Open
Abstract
A role of gut-brain axis emerges in the pathophysiology of anorexia nervosa and maintaining adapted physical activity during refeeding remains discussed. We aimed to assess gastrointestinal protein metabolism and investigate the contribution of physical activity during refeeding in C57BL/6 mice with activity-based anorexia (ABA). ABA mice exhibited lower body weight and food intake with increase of lean mass/fat mass ratio and fat oxidation. Colonic permeability was increased in ABA. Ad libitum food access was then restored and ABA group was divided into two subgroups, with access to running wheel (ABA-PA) or not (ABA-NPA). After refeeding, fat free mass was completely restored only in ABA-PA. Colonic permeability was enhanced in ABA-NPA. Finally, muscle kynurenine conversion into kynurenic acid was lower in ABA-NPA who also exhibited altered behavior. Maintaining physical activity during refeeding may thus limit colonic hyperpermeability and improve behavior in anorectic mice.
Collapse
Affiliation(s)
- Najate Achamrah
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Rouen University Hospital, Nutrition unit, Rouen, France
| | - Séverine Nobis
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Jonathan Breton
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Pierre Jésus
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Liliana Belmonte
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Rouen University Hospital, Nutrition unit, Rouen, France
| | - Brigitte Maurer
- Rouen University Hospital, Laboratory of Medical Biochemistry, Rouen, France
| | - Romain Legrand
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Christine Bôle-Feysot
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Jean Luc do Rego
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Animal Behavior Platform SCAC, University of Rouen, France
| | - Alexis Goichon
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Jean Claude do Rego
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Animal Behavior Platform SCAC, University of Rouen, France
| | - Pierre Déchelotte
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Rouen University Hospital, Nutrition unit, Rouen, France
| | - Sergueï O Fetissov
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
| | - Sophie Claeyssens
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Rouen University Hospital, Laboratory of Medical Biochemistry, Rouen, France
| | - Moïse Coëffier
- Normandie Univ, INSERM Unit 1073, UR, France
- Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen, France
- Rouen University Hospital, Nutrition unit, Rouen, France
| |
Collapse
|
8
|
Goichon A, Bertrand J, Chan P, Lecleire S, Coquard A, Cailleux AF, Vaudry D, Déchelotte P, Coëffier M. Enteral delivery of proteins enhances the expression of proteins involved in the cytoskeleton and protein biosynthesis in human duodenal mucosa. Am J Clin Nutr 2015; 102:359-67. [PMID: 26109581 PMCID: PMC7109707 DOI: 10.3945/ajcn.114.104216] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Accepted: 05/20/2015] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Amino acids are well known to be key effectors of gut protein turnover. We recently reported that enteral delivery of proteins markedly stimulated global duodenal protein synthesis in carbohydrate-fed healthy humans, but specifically affected proteins remain unknown. OBJECTIVE We aimed to assess the influence of an enteral protein supply on the duodenal mucosal proteome in carbohydrate-fed humans. DESIGN Six healthy volunteers received for 5 h, on 2 occasions and in random order, either an enteral infusion of maltodextrins alone (0.25 g · kg⁻¹ · h⁻¹) mimicking the fed state or maltodextrins with a protein powder (0.14 g proteins · kg⁻¹ · h⁻¹). Endoscopic duodenal biopsy specimens were then collected and frozen until analysis. A 2-dimensional polyacrylamide gel electrophoresis-based comparative proteomics analysis was then performed, and differentially expressed proteins (at least ±1.5-fold change; Student's t test, P < 0.05) were identified by mass spectrometry. Protein expression changes were confirmed by Western blot analysis. RESULTS Thirty-two protein spots were differentially expressed after protein delivery compared with maltodextrins alone: 28 and 4 spots were up- or downregulated, respectively. Among the 22 identified proteins, 11 upregulated proteins were involved either in the cytoskeleton (ezrin, moesin, plastin 1, lamin B1, vimentin, and β-actin) or in protein biosynthesis (glutamyl-prolyl-transfer RNA synthetase, glutaminyl-transfer RNA synthetase, elongation factor 2, elongation factor 1δ, and eukaryotic translation and initiation factor 3 subunit f). CONCLUSIONS Enteral delivery of proteins altered the duodenal mucosal proteome and mainly stimulated the expression of proteins involved in cytoskeleton and protein biosynthesis. These results suggest that protein supply may affect intestinal morphology by stimulating actin cytoskeleton remodeling.
Collapse
Affiliation(s)
- Alexis Goichon
- INSERM Unit 1073, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France
| | - Julien Bertrand
- INSERM Unit 1073, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France
| | - Philippe Chan
- Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France; Platform of Proteomics PISSARO, Mont-Saint-Aignan, France
| | - Stéphane Lecleire
- INSERM Unit 1073, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France; Gastroenterology, Rouen University Hospital, Rouen, France
| | | | - Anne-Françoise Cailleux
- Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France; Clinical Investigation Centre CIC 1404-INSERM, Rouen, France
| | - David Vaudry
- Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France; INSERM Unit 982, Mont-Saint-Aignan, France; and Platform of Proteomics PISSARO, Mont-Saint-Aignan, France
| | - Pierre Déchelotte
- INSERM Unit 1073, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen University, Rouen, France; Departments of Nutrition,
| | - Moïse Coëffier
- INSERM Unit 1073, Rouen, France; Clinical Investigation Centre CIC 1404-INSERM, Rouen, France
| |
Collapse
|
9
|
Bertrand J, Marion-Letellier R, Azhar S, Chan P, Legrand R, Goichon A, Ghouzali I, Aziz M, Vaudry D, Savoye G, Déchelotte P, Coëffier M. Glutamine enema regulates colonic ubiquitinated proteins but not proteasome activities during TNBS-induced colitis leading to increased mitochondrial activity. Proteomics 2015; 15:2198-210. [PMID: 25689466 DOI: 10.1002/pmic.201400304] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2014] [Revised: 01/12/2015] [Accepted: 02/12/2015] [Indexed: 12/22/2022]
Abstract
Ubiquitin proteasome system contributes to the regulation of intestinal inflammatory response as its inhibition is associated with tissue damage improvement. We aimed to evaluate whether glutamine is able to limit inflammation by targeting ubiquitin proteasome system in experimental colitis. Colitis was induced in male rats by intrarectal instillation of 2-4-6-trinitrobenzen sulfonic acid (TNBS) at day 1. From day 2 to day 6, rats daily received either an intrarectal instillation of PBS (TNBS/PBS group) or glutamine (TNBS/Gln). Rats were euthanized at day 7 and colonic samples were taken to evaluate ubiqutinated proteins by proteomic approach combining 2D electrophoresis and immunoblots directed against ubiquitin. Results were then confirmed by evaluating total expression of proteins and mRNA levels. Survival rate, TNFα, and IL-1β mRNA were improved in TNBS/Gln compared with TNBS/PBS (p < 0.05). Proteasome activities were affected by TNBS but not by glutamine. We identified eight proteins that were less ubiquitinated in TNBS/PBS compared with controls with no effect of glutamine. Four proteins were more ubiquitinated in TNBS/PBS group and restored in TNBS/Gln group. Finally, 12 ubiquitinated proteins were only affected by glutamine. Among proteins affected by glutamine, eight proteins (GFPT1, Gapdh, Pkm2, LDH, Bcat2, ATP5a1, Vdac1, and Vdac2) were involved in metabolic pathways. In conclusion, glutamine may regulate ubiquitination process during intestinal inflammation.
Collapse
Affiliation(s)
- Julien Bertrand
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France
| | - Rachel Marion-Letellier
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France
| | - Saïda Azhar
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France
| | - Philippe Chan
- Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France.,Plateform of Proteomics PISSARO, Mont-Saint-Aignan, France
| | - Romain Legrand
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France
| | - Alexis Goichon
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France
| | - Ibtissem Ghouzali
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France
| | - Moutaz Aziz
- Laboratory of Anatomo-Pathology, Rouen University Hospital, Rouen, France
| | - David Vaudry
- Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France.,Plateform of Proteomics PISSARO, Mont-Saint-Aignan, France.,INSERM Unit 982, Mont-Saint-Aignan, France
| | - Guillaume Savoye
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France.,Department of Gastroenterology, Rouen University Hospital, Rouen, France
| | - Pierre Déchelotte
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France.,Department of Nutrition, Rouen University Hospital, Rouen, France
| | - Moïse Coëffier
- INSERM Unit 1073, Nutrition Inflammation and Gut Brain Axis, Rouen, France.,Institute for Research and Innovation in Biomedicine, University of Rouen, Rouen, France.,Department of Nutrition, Rouen University Hospital, Rouen, France
| |
Collapse
|
10
|
Enteral glutamine infusion modulates ubiquitination of heat shock proteins, Grp-75 and Apg-2, in the human duodenal mucosa. Amino Acids 2014; 46:1059-67. [PMID: 24449167 DOI: 10.1007/s00726-014-1670-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2013] [Accepted: 01/08/2014] [Indexed: 12/16/2022]
Abstract
Glutamine, the most abundant amino acid in the human body, plays several important roles in the intestine. Previous studies showed that glutamine may affect protein expression by regulating ubiquitin-proteasome system. We thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa. Five healthy male volunteers were included and received during 5 h, on two occasions and in a random order, either an enteral infusion of maltodextrins alone (0.25 g kg(-1) h(-1), control), mimicking carbohydrate-fed state, or maltodextrins with glutamine (0.117 g kg(-1) h(-1), glutamine). Endoscopic duodenal biopsies were then taken. Total cellular protein extracts were separated by 2D gel electrophoresis and analyzed by an immunodetection using anti-ubiquitin antibody. Differentially ubiquitinated proteins were then identified by liquid chromatography-electrospray ionization MS/MS. Five proteins were differentially ubiquitinated between control and glutamine conditions. Among these proteins, we identified two chaperone proteins, Grp75 and hsp74. Grp75 was less ubiquitinated after glutamine infusion compared with control. In contrast, hsp74, also called Apg-2, was more ubiquitinated after glutamine. In conclusion, we provide evidence that glutamine may regulate ubiquitination processes of specific proteins, i.e., Grp75 and Apg-2. Grp75 has protective and anti-inflammatory properties, while Apg-2 indirectly regulates stress-induced cell survival and proliferation through interaction with ZO-1. Further studies should confirm these results in stress conditions.
Collapse
|
11
|
Goichon A, Bertrand J, Chan P, Lecleire S, Coquard A, Cailleux AF, Vaudry D, Déchelotte P, Coëffier M. O35 Analyse du protéome duodénal après apport entéral de protéines chez l’homme : augmentation de l’expression de protéines impliquées dans la structure cellulaire et la synthèse protéique. NUTR CLIN METAB 2013. [DOI: 10.1016/s0985-0562(13)70307-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
Kimball SR. Does enteral protein administration stimulate duodenal mucosa protein synthesis through an mTORC1-independent signaling pathway? Am J Clin Nutr 2013; 97:235-6. [PMID: 23283499 PMCID: PMC3545679 DOI: 10.3945/ajcn.112.054999] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|